A subscription to JoVE is required to view this content. Sign in or start your free trial.
Here, we describe a protocol to obtain crude venom extract from sea anemone and detect its hemolytic and phospholipase activity.
Sea anemone venom composition includes polypeptide and non-proteins molecules. Cytolytic components have a high biotechnological and biomedical potential for designing new molecular tools. Sea anemone venom locates in glandular cells from ectoderm and sub-cellular structures called nematocysts, both of which are distributed throughout the sea anemone body. This characteristic implies challenges because the cells and nematocyst must be lysed to release the venom components with other non-toxic molecules. Therefore, first, the venom is derived from a crude extract (mixture of different and diverse molecules and tissue debris). The next step is to detect polypeptides with specific bioactivities. Here, we describe an efficient strategy to obtain the sea anemone crude extract and bioassay to identify the presence of cytolysins. The first step involves inexpensive and straightforward techniques (stirred and freeze-thaw cycle) to release cytolysins. We obtained the highest cytolytic activity and protein (~500 mg of protein from 20 g of dry weight). Next, the polypeptide complexity of the extract was analyzed by SDS-PAGE gel detecting proteins with molecular weights between 10 kDa and 250 kDa. In the hemolytic assay, we used sheep red blood cells and determined HU50 (11.1 ± 0.3 µg/mL). In contrast, the presence of phospholipases in the crude extract was determined using egg yolk as a substrate in a solid medium with agarose. Overall, this study uses an efficient and inexpensive protocol to prepare the crude extract and applies replicable bioassays to identify cytolysins, molecules with biotechnological and biomedical interests.
Marine animals are a rich source of biologically active compounds. In recent decades, the composition of sea anemone venom has attracted scientific attention since it comprises a diversity of polypeptides with hemolytic, cytotoxic, enzymatic (phospholipase, protease, chitinase), and neurotoxic activity and inhibitory effects on proteolytic activity1. In addition, these polypeptides are potential sources for the development of molecular tools in biotechnological and therapeutical use2,3.
There are few reports about sea anemone venom and its molecular components due to the complexity of obtaining the venom, even isolation, and characterization of toxins. The extraction methods used in the reports involved lysis and emptying the contents of cells that are related and unrelated to the venom production1.
A particular characteristic in all cnidarians is the absence of a system for production and release of the venom centralized in a single anatomical region. Instead, the nematocysts are structures that keep the venom4,5. Other types of cells, called epidermal gland cells, also secrete toxins and are also distributed throughout the body of sea anemones6.
The first and most crucial challenge in obtaining the venom is the generation of an extract with sufficient manipulation in subsequent processes, without the inactivation or degradation of labile proteins. Next, the cells must be lysed, and the components-in this case, polypeptides must be efficiently and quickly extracted, avoiding proteolysis and hydrolysis while eliminating other cellular components7.
Different methods are used to obtain the crude extract of a sea anemone; some involve sacrificing the organism while others allow it to be kept alive. Methods that imply the use of the organism´s whole body allow for the release of most toxins from the venom8, compared to methods that keep organisms alive, which extract only some components of the venom9. The preparation of an extract requires evaluating the presence and potency of a substance of interest through a specific bioassay, which includes strategies to observe the pharmacological effects by in vivo or in vitro methods10.
Sea anemone venom contains cytolytic polypeptides, pore-forming toxins (PFTs)11, and phospholipases12; these molecules are models in the study of protein-lipid interaction, molecular tools in cancer therapy, and biosensors based on nanopore3. The classification of sea anemone PFTs is carried out according to their size or molecular weight, from 5 kDa to 80 kDa. The 20 kDa PFT, the most studied and known as actinoporins11, is of particular interest for its biomedical potential in the development of molecular tools for possible applications as anticancer, antimicrobial, and nanopore-based biosensors. Another cytolysin, including phospholipases, specifically phospholipase A2 (PLA2)13, releases a fatty acid due and hydrolyzes phospholipids, destabilizing the cell membrane. Due to this mechanism of action, PLA2 promises to be an essential model for the study and applications in inflammatory diseases. It could serve as a model for studies of lipid behavior in the cell membrane14.
Here, we describe an efficient protocol for obtaining the crude extract from sea anemone Anthopleura dowii Verrill, 1869, and detecting hemolysins and phospholipases. Both are relevant toxins that could be used as a template to design new molecular tools.
The sea anemones were collected according to guidelines of the National Commission for Aquaculture, Fisheries, and Food of the Federal Government of Mexico (permit number PPF / DGOPTA 07332.250810.4060). Bioethics Committee of the Institute of Biotechnology, National Autonomous University of Mexico approved all the experiments with sea anemones. The sheep blood sample was purchased at the Center for Practical Teaching and Research in Animal Production and Health (CEPIPSA, National Autonomous University of Mexico).
1. Organism collection
2. Tissue hydration
3. Toxin release
4. Quantitation of total protein
5. Determine polypeptide venom complexity
6. Protein staining
7. Prepare red blood cell solution
8. Hemolysis assay
9. Phospholipase assay
The representative results of the protocol used to obtain the crude extract of sea anemone showed that combining two techniques (agitation and cycles of freezing and thawing) produced an efficient discharge of nematocysts, and the total amount of protein was 500 mg (8 mg/mL) (Figure 3).
The crude extract's protein complexity could be observed from 10 kDa and greater than 250 kDa through SDS-PAGE electrophoresis. In addition, cytolysins were detected in the mol...
The high demand for new compounds with applications in different fields of science and industry has led to the study of venom. Venom represents a rich source of molecules that serves as a template for generating new molecular tools. However, the complexity of these venoms requires the implementation and combination of various methods to obtain and study them.
Here, we show a method for obtaining and analyzing the venom of the sea anemone Anthopleura dowii, Verrill 1869, which can be u...
The authors declare that they have no competing interest in relation to the publication of this paper.
This work was supported by Programa de Apoyo a Proyectos de Investigación e Innovación Tecnológica (PAPIIT), with a grant number IT200819. The authors acknowledge to Tom Musselman, Rock Paper Editing, LLC, for checking the English grammar of this manuscript; and the technical assistance of Samanta Jiménez (CICESE, Ensenada), and Juan Manuel Barbosa Castillo (Instituto de Fisiología Celular, UNAM). We also thank to Dr Augusto César Lizarazo Chaparro (CEPIPSA) for obtaining sheep blood. We especially thank Dr José Saniger Blesa, ICAT-UNAM, for the facilities in his laboratory for the video recording.
Name | Company | Catalog Number | Comments |
15 mL conical centrifuge tube | Corning | 430766 | |
2-Bromophenol blue | Sigma | B75808 | |
2-mercaptoetanol | Sigma-Aldrich | M6250-100ML | |
50 mL conical centrifuge tubes | Corning | 430828 | |
Acetic Acid Glacial | J.T. Baker | 9515-03 | |
Acrylamide | Promega | V3115 | |
Agarose | Promega | V3125 | |
Bisacrylamide | Promega | V3143 | |
Bovine Serum Albumin Fraction V | Sigma | A3059-100G | |
Bradford Protein Assays | Bio-Rad | 5000006 | |
Calcium chloride | Sigma-Aldrich | C3306 | |
Cell culture plates 96 well, V-bottom | Corning | 3894 | |
Centrifuge | Eppendorf | 5804R | |
Centrifuge tubes | Corning | CLS430829 | |
ChemiDoc MP system | Bio-Rad | 1708280 | |
Citric acid | Sigma-Aldrich | 251275 | |
Clear flat.bottom 96-Well Plates | Thermo Scientific | 3855 | |
Coomassie Brilliant Blue G-250 | Bio-Rad | #1610406 | |
Coomassie brilliant blue R-250 | Bio-Rad | 1610400 | |
Dextrose | J.T. Baker | 1916-01 | |
Ductless Enclosure | Labconco | Vertical | https://imagej.nih.gov/ij ImageJ 1.53c |
Gel Doc EZ | Bio Rad. | Gel Documentation System | |
Glycerol | Sigma-Aldrich | G5516-4L | |
Hemocytometer | Marienfeld | 650030 | |
ImageJ (Software) | NIH, USA | Version 1.53c | |
Incubator 211 | Labnet | I5211 DS | |
Methanol | J.T. Baker | 9049-03 | |
Mini-PROTEAN tetra cell | Bio-Rad | 1658000EDU | |
Na2HPO4 | J.T. Baker | 3824-01 | |
NaCl | J.T. Baker | 3624-01 | |
NaH2PO4.H2O | J.T. Baker | 3818-05 | |
Origin software | version 9 | To design the plot with sigmoidal adjustments | |
Petridish | Falcon | 351007 | |
Pipetman kit | Gilson | F167380 | |
Precast mini gel | BioRad | 1658004 | |
Prestained Protein Ladder | Thermo Scientific | 26620 | |
Protease Inhibitor Cocktail | Roche | 11836153001 | |
Protein Assay Dye Reagent Concentrate | Bio-Rad | 5000006 | |
Rhodamine 6G | Sigma-Aldrich | 252433 | |
SDS | Sigma-Aldrich | L4509 | |
Sodium citrate dihydrate | JT Baker | 3646-01 | |
Spectrophotometer | THERMO SCIENTIFIC | G10S UV-VIS | |
Tris Base | Sigma-Aldrich | 77-86-1 | |
Volt Power Supply | Hoefer | PS300B |
Request permission to reuse the text or figures of this JoVE article
Request PermissionThis article has been published
Video Coming Soon
ISSN 2578-2037
Copyright © 2025 MyJoVE Corporation. All rights reserved
We use cookies to enhance your experience on our website.
By continuing to use our website or clicking “Continue”, you are agreeing to accept our cookies.